RSS Items

A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2

Saturday, October 28, 2023 - 4:00 AM

(1) Background: We previously reported the development of a recombinant protein SARS-CoV-2 vaccine, consisting of the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein, adjuvanted with aluminum hydroxide (alum) and CpG oligonucleotides

A recombinant spike-XBB.1.5 protein vaccine induces broad-spectrum immune responses against XBB.1.5-included Omicron variants of SARS-CoV-2

Monday, May 01, 2023 - 4:00 AM

The XBB.1.5 subvariant has drawn great attention owing to its exceptionality in immune evasion and transmissibility. Therefore, it is essential to develop a universally protective coronavirus disease 2019 vaccine against various strains of Omicron

A record investment in innovative cancer care

Friday, March 21, 2025 - 10:45 AM

Alberta’s government is partnering with Siemens Healthineers and the Alberta Cancer Foundation to improve health outcomes for Albertans diagnosed with cancer.

A record investment in innovative cancer care | Un investissement sans précédent dans l’innovation des traitements contre le cancer

Friday, March 21, 2025 - 10:45 AM

Alberta’s government is partnering with Siemens Healthineers and the Alberta Cancer Foundation to improve health outcomes for Albertans diagnosed with cancer.

A Recovery Journey That Isn’t

Tuesday, January 18, 2022 - 12:00 PM

David Sanchez’ debut novel, “All Day Is a Long Time,” paints a kaleidoscopic portrait of life with addiction.

A Reduction in the Number of Hospitalized Cases of Acute Meningitis during the COVID-19 Pandemic in Japan

Sunday, March 03, 2024 - 4:00 AM

Objective The changes in the prevalence of acute meningitis during the coronavirus disease 2019 (COVID-19) pandemic remain unclear. This study aimed to compare the prevalence of acute meningitis before and during the COVID-19 pandemic in Japan

A reference standard for urinary tract infection research: a multidisciplinary Delphi consensus study

Friday, March 08, 2024 - 4:00 AM

The absence of a consensus-based reference standard for urinary tract infection (UTI) research adversely affects the internal and external validity of diagnostic and therapeutic studies. This omission hinders the accumulation of evidence for a

A reflection on COVID-19 and oral mucosal lesion: a systematic review

Wednesday, January 03, 2024 - 4:00 AM

INTRODUCTION: The aim of this systematic review is to provide a clinical update of the current knowledge on COVID-19 and oral mucosal lesions, to analyze the types and prevalence of oral mucosal lesions in patients with COVID-19, and to clarify the

A reflection on participatory research methodologies in the light of the COVID-19 - lessons learnt from the European Research Project TRIPS

Wednesday, August 30, 2023 - 4:00 AM

The coronavirus disease (COVID-19) outbreak has had considerable impacts on research projects, particularly those adopting participatory approaches. This paper reflects on the methodological adaptations employed by the European research project TRIPS

A regional genomic surveillance program is implemented to monitor the occurrence and emergence of SARS-CoV-2 variants in Yubei District, China

Monday, January 08, 2024 - 4:00 AM

CONCLUSIONS: Our monitoring reveals the rapid replacement of the previously prevalent BA.5.2.48 variant by XBB and its sub-variants, underscoring the ineffectiveness of herd immunity and breakthrough BA.5 infections against XBB variants. Given the